Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Subcutaneous omalizumab + steroid vs placebo + steroid (stable steroid)

Exacerbations · people with asthma

Subcutaneous omalizumab + steroid probably leads to lower number of participants with at least one exacerbation All asthmatic… compared with placebo + steroid (stable steroid) (moderate certainty).

1 finding from 1 review

Omalizumab for asthma in adults and children 2014 · Cochrane Headline outcomes only
OR 0.55 [0.46, 0.65]
10 studies · 3261 participants
Moderate